Capital Fund Management (CFM)’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-91,917
| Closed | -$676K | – | 751 |
|
|
2023
Q2 | $676K | Buy |
+91,917
| New | +$676K | ﹤0.01% | 545 |
|
|
2022
Q4 | – | Sell |
-70,498
| Closed | -$1.48M | – | 629 |
|
|
2022
Q3 | $1.48M | Sell |
70,498
-16,705
| -19% | -$351K | 0.01% | 355 |
|
|
2022
Q2 | $2.71M | Buy |
87,203
+48,773
| +127% | +$1.51M | 0.02% | 304 |
|
|
2022
Q1 | $1.58M | Buy |
+38,430
| New | +$1.58M | 0.01% | 408 |
|
|
2021
Q3 | – | Sell |
-24,219
| Closed | -$1.53M | – | 666 |
|
|
2021
Q2 | $1.53M | Buy |
+24,219
| New | +$1.53M | 0.01% | 374 |
|
|
2020
Q4 | – | Sell |
-21,726
| Closed | -$2.24M | – | 648 |
|
|
2020
Q3 | $2.24M | Buy |
+21,726
| New | +$2.24M | 0.03% | 255 |
|
|
2016
Q3 | – | Sell |
-15,600
| Closed | -$439K | – | 920 |
|
|
2016
Q2 | $439K | Buy |
+15,600
| New | +$439K | ﹤0.01% | 675 |
|